These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2861914)

  • 21. Stereospecific binding of timolol, a beta-adrenergic blocking agent.
    Tocco DJ; Hooke KF; Deluna FA; Duncan AE
    Drug Metab Dispos; 1976; 4(4):323-9. PubMed ID: 8286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the beta-adrenoceptor blocking properties and pharmacokinetics of SL 75212 and propranolol in man [proceedings].
    Bianchetti G; Chauvin M; Giudicelli JF; Gomeni R; Kilborn JR; Morselli PL; Richer C; Thuillez C
    Br J Clin Pharmacol; 1979 Oct; 8(4):407P-708P. PubMed ID: 41559
    [No Abstract]   [Full Text] [Related]  

  • 23. Sensitive gas chromatographic method for the determination in plasma of FM 24, 1-(2-exo-bicyclo[2,2,1]hept-2-ylphenoxy)-3[(1-methylethyl)amino]-2-propanol, a new beta-adrenoceptor blocking agent.
    Bernard N; Cuisinaud G; Jozefczak C; Seccia M; Ferry N; Sassard J
    J Chromatogr; 1980 Jul; 183(1):99-103. PubMed ID: 6105161
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics of the new beta-adrenoceptor blocker SL 75212 in man after repeated oral administration [proceedings].
    Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Morselli PL; Thébault JJ; Trocherie S
    Br J Clin Pharmacol; 1979 Oct; 8(4):408P. PubMed ID: 41560
    [No Abstract]   [Full Text] [Related]  

  • 25. [Identification of urinary metabolites of befunolol in dog and man principally by mass spectrometry (author's transl)].
    Tohno M; Kimura K; Nagahara M; Sakai Y; Ofuji T; Nadai T
    Yakugaku Zasshi; 1979 Sep; 99(9):944-57. PubMed ID: 44723
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypotensive action of propranolol and a new beta-blocking agent, D-32 in conscious normotensive and renal hypertensive dogs.
    Himori N; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):4-18. PubMed ID: 8021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacokinetics and metabolism of bevantolol.
    Latts JR
    Angiology; 1986 Mar; 37(3 Pt 2):221-5. PubMed ID: 2871781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Syntheses and beta-adrenergic binding affinities of (R)- and (S)-fluoronaphthyloxypropanolamines.
    Adejare A; Deal SA; Day MS
    Chirality; 1999; 11(2):144-8. PubMed ID: 9951404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Species differences in the stereoselective hydrolysis of esmolol by blood esterases.
    Quon CY; Mai K; Patil G; Stampfli HF
    Drug Metab Dispos; 1988; 16(3):425-8. PubMed ID: 2900735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat].
    Klemm W; Wenzel A
    Pharmazie; 1975 Oct; 30(10):675-7. PubMed ID: 695
    [No Abstract]   [Full Text] [Related]  

  • 31. The pharmacokinetics of dl- and l-moprolol in the human.
    Harvengt C; Desager JP
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):57-61. PubMed ID: 6120901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The spectrofluorimetric estimation and buccal absorption of SL 75212, a novel beta-adrenoceptor antagonist [proceedings].
    Davis BJ; Turner P
    Br J Clin Pharmacol; 1979 Oct; 8(4):405P. PubMed ID: 41558
    [No Abstract]   [Full Text] [Related]  

  • 33. Tissue distribution of exaprolol in rat.
    Faberová V; Trnovec T; Zemánek M; Bezek S; Durisová M; Tomcíková O
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):11-3. PubMed ID: 2863149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comment on the comment on nadolol article.
    Drug Intell Clin Pharm; 1981; 15(7-8):603. PubMed ID: 6113946
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of a high-performance liquid chromatographic method for the analysis of enatiomer/enantiomer interaction in oxidative metabolism of bunitrolol in rat liver microsomes.
    Narimatsu S; Huang Y; Mizukami T; Masubuchi Y; Suzuki T
    Anal Biochem; 1994 Oct; 222(1):256-61. PubMed ID: 7856858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes.
    Innis RB; Corrēa FM; Synder SH
    Life Sci; 1979 Jun; 24(24):2255-64. PubMed ID: 41147
    [No Abstract]   [Full Text] [Related]  

  • 37. Polymorphism in drug metabolism.
    Balant L; Dayer P; Fabre J
    Br Med J; 1978 Nov; 2(6147):1299. PubMed ID: 30518
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
    Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption of the beta-adrenergic-blocking agent, nadolol, by mice, rats, hamsters, rabbits, dogs, monkeys, and man: an unusual species difference.
    Dreyfuss J; Shaw JM; Ross JJ
    Xenobiotica; 1978 Aug; 8(8):503-8. PubMed ID: 29379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (-)-S-[3H]CGP-12177 and its use to determine the rate constants of unlabeled beta-adrenergic antagonists.
    Affolter H; Hertel C; Jaeggi K; Portenier M; Staehelin M
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):925-9. PubMed ID: 2858094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.